522 related articles for article (PubMed ID: 14980717)
1. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
4. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
5. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
6. Enforced expression of METCAM/MUC18 increases tumorigenesis of human prostate cancer LNCaP cells in nude mice.
Wu GJ; Wu MW; Wang C; Liu Y
J Urol; 2011 Apr; 185(4):1504-12. PubMed ID: 21334670
[TBL] [Abstract][Full Text] [Related]
7. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
8. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells.
Zeng G; Cai S; Liu Y; Wu GJ
Gene; 2012 Jan; 492(1):229-38. PubMed ID: 22057013
[TBL] [Abstract][Full Text] [Related]
9. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
[TBL] [Abstract][Full Text] [Related]
10. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
11. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
12. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
13. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
Hall CL; Dai J; van Golen KL; Keller ET; Long MW
Cancer Res; 2006 Sep; 66(17):8648-54. PubMed ID: 16951179
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
15. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
17. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
18. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells.
Zvieriev V; Wang JC; Chevrette M
Biochem Biophys Res Commun; 2005 Nov; 337(2):498-504. PubMed ID: 16198313
[TBL] [Abstract][Full Text] [Related]
20. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
